TY - JOUR
T1 - Jansen-de Vries syndrome
T2 - Expansion of the PPM1D clinical and phenotypic spectrum in 34 families
AU - Wojcik, Monica H.
AU - Srivastava, Siddharth
AU - Agrawal, Pankaj B.
AU - Balci, Tugce B.
AU - Callewaert, Bert
AU - Calvo, Pier Luigi
AU - Carli, Diana
AU - Caudle, Michelle
AU - Colaiacovo, Samantha
AU - Cross, Laura
AU - Demetriou, Kalliope
AU - Drazba, Katy
AU - Dutra-Clarke, Marina
AU - Edwards, Matthew
AU - Genetti, Casie A.
AU - Grange, Dorothy K.
AU - Hickey, Scott E.
AU - Isidor, Bertrand
AU - Küry, Sébastien
AU - Lachman, Herbert M.
AU - Lavillaureix, Alinoe
AU - Lyons, Michael J.
AU - Marcelis, Carlo
AU - Marco, Elysa J.
AU - Martinez-Agosto, Julian A.
AU - Nowak, Catherine
AU - Pizzol, Antonio
AU - Planes, Marc
AU - Prijoles, Eloise J.
AU - Riberi, Evelise
AU - Rush, Eric T.
AU - Russell, Bianca E.
AU - Sachdev, Rani
AU - Schmalz, Betsy
AU - Shears, Deborah
AU - Stevenson, David A.
AU - Wilson, Kate
AU - Jansen, Sandra
AU - de Vries, Bert B.A.
AU - Curry, Cynthia J.
N1 - Publisher Copyright:
© 2023 Wiley Periodicals LLC.
PY - 2023/7
Y1 - 2023/7
N2 - Jansen-de Vries syndrome (JdVS) is a neurodevelopmental condition attributed to pathogenic variants in Exons 5 and 6 of PPM1D. As the full phenotypic spectrum and natural history remain to be defined, we describe a large cohort of children and adults with JdVS. This is a retrospective cohort study of 37 individuals from 34 families with disease-causing variants in PPM1D leading to JdVS. Clinical data were provided by treating physicians and/or families. Of the 37 individuals, 27 were male and 10 female, with median age 8.75 years (range 8 months to 62 years). Four families document autosomal dominant transmission, and 32/34 probands were diagnosed via exome sequencing. The facial gestalt, including a broad forehead and broad mouth with a thin and tented upper lip, was most recognizable between 18 and 48 months of age. Common manifestations included global developmental delay (35/36, 97%), hypotonia (25/34, 74%), short stature (14/33, 42%), constipation (22/31, 71%), and cyclic vomiting (6/35, 17%). Distinctive personality traits include a hypersocial affect (21/31, 68%) and moderate-to-severe anxiety (18/28, 64%). In conclusion, JdVS is a clinically recognizable neurodevelopmental syndrome with a characteristic personality and distinctive facial features. The association of pathogenic variants in PPM1D with cyclic vomiting bears not only medical attention but also further pathogenic and mechanistic evaluation.
AB - Jansen-de Vries syndrome (JdVS) is a neurodevelopmental condition attributed to pathogenic variants in Exons 5 and 6 of PPM1D. As the full phenotypic spectrum and natural history remain to be defined, we describe a large cohort of children and adults with JdVS. This is a retrospective cohort study of 37 individuals from 34 families with disease-causing variants in PPM1D leading to JdVS. Clinical data were provided by treating physicians and/or families. Of the 37 individuals, 27 were male and 10 female, with median age 8.75 years (range 8 months to 62 years). Four families document autosomal dominant transmission, and 32/34 probands were diagnosed via exome sequencing. The facial gestalt, including a broad forehead and broad mouth with a thin and tented upper lip, was most recognizable between 18 and 48 months of age. Common manifestations included global developmental delay (35/36, 97%), hypotonia (25/34, 74%), short stature (14/33, 42%), constipation (22/31, 71%), and cyclic vomiting (6/35, 17%). Distinctive personality traits include a hypersocial affect (21/31, 68%) and moderate-to-severe anxiety (18/28, 64%). In conclusion, JdVS is a clinically recognizable neurodevelopmental syndrome with a characteristic personality and distinctive facial features. The association of pathogenic variants in PPM1D with cyclic vomiting bears not only medical attention but also further pathogenic and mechanistic evaluation.
KW - Jansen-de Vries syndrome
KW - PPM1D
KW - cyclic vomiting
KW - developmental delay
KW - hypersocial personality
UR - http://www.scopus.com/inward/record.url?scp=85159181090&partnerID=8YFLogxK
U2 - 10.1002/ajmg.a.63226
DO - 10.1002/ajmg.a.63226
M3 - Article
C2 - 37183572
AN - SCOPUS:85159181090
SN - 1552-4825
VL - 191
SP - 1900
EP - 1910
JO - American Journal of Medical Genetics, Part A
JF - American Journal of Medical Genetics, Part A
IS - 7
ER -